Australia's Proteomics International soars on distribution deal with Healius
BUZZ-Australia's Proteomics International soars on distribution deal with Healius ** Proteomics International PIQ.AX rise as much as 50% to A$0.225, their highest level since May 6
** Signs exclusive pathology distribution partner with Healius HLS.AX for its Promarker portfolio of predictive and diagnostic blood tests in Australia
** About 1.1 mln shares change hands, 1.9x the 30-day average of 579,223
** Stock down 71% YTD, including moves in the current session
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius